Cas no 94994-39-5 (4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid)

4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid structure
94994-39-5 structure
Product Name:4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid
CAS No:94994-39-5
MF:C10H19NO4
MW:217.26216340065
MDL:MFCD09831984
CID:1091068
PubChem ID:10656390
Update Time:2024-10-25

4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Chemical and Physical Properties

Names and Identifiers

    • 4-((tert-Butoxycarbonyl)(methyl)amino)butanoic acid
    • 5-Hydroxymethylisoxazole-3-carboxylic acid ethyl ester
    • 4-[(TERT-BUTOXYCARBONYL)(METHYL)AMINO]BUTANOIC ACID
    • 4-[[(1,1-Dimethylethoxy)carbonyl]methylamino]butanoic acid (ACI)
    • 4-[(tert-Butoxycarbonyl)(methyl)amino]butyric acid
    • 4-[N-(tert-Butoxycarbonyl)-N-methylamino]butyric acid
    • 4-[N-Methyl-N-(tert-butoxycarbonyl)amino]butyric acid
    • F8880-8286
    • AB6481
    • 4-(N-tert-butoxycarbonyl-N-methylamino)butyric acid
    • EN300-49664
    • 4-((tert-butoxycarbonyl)(methyl)amino)butanoicacid
    • 4-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]butanoic Acid
    • SY107643
    • SCHEMBL693386
    • PXAKQDWAISFHCM-UHFFFAOYSA-N
    • 4-[{[(1,1-Dimethylethyl)oxy]carbonyl}(methyl)amino)butanoic acid
    • Z382704896
    • Boc-N-methyl-gamma-aminobutyric acid
    • 4-{[(tert-butoxy)carbonyl](methyl)amino}butanoic acid
    • 94994-39-5
    • 4-(N-t-butyloxycarbonyl-N-methylamino)butanoic acid
    • CS-W005842
    • AS-19947
    • 4-(N-BOC-N-METHYL-AMINO)-BUTYRIC ACID
    • MFCD09831984
    • 4-[(TERT-BUTOXYCARBONYL)(METHYL)AMINO]BUTANOICACID
    • 4-((Boc)(methyl)amino)butanoic acid
    • 4-(tert-butoxycarbonyl-methyl-amino)-butyric acid
    • 4-[{[(1,1-dimethylethyl)oxy]carbonyl}(methyl)amino]butanoic acid
    • 4-([(tert-Butoxy)carbonyl](methyl)amino)butanoic acid
    • AKOS008126011
    • 4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid
    • MDL: MFCD09831984
    • Inchi: 1S/C10H19NO4/c1-10(2,3)15-9(14)11(4)7-5-6-8(12)13/h5-7H2,1-4H3,(H,12,13)
    • InChI Key: PXAKQDWAISFHCM-UHFFFAOYSA-N
    • SMILES: O=C(N(CCCC(O)=O)C)OC(C)(C)C

Computed Properties

  • Exact Mass: 217.13100
  • Monoisotopic Mass: 217.13140809g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 5
  • Heavy Atom Count: 15
  • Rotatable Bond Count: 7
  • Complexity: 232
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 1
  • Topological Polar Surface Area: 66.8?2

Experimental Properties

  • Melting Point: 62-65°C
  • PSA: 66.84000
  • LogP: 1.71810

4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Security Information

4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-FZ296-5g
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid
94994-39-5 98%
5g
3507CNY 2021-05-08
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-FZ296-1g
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid
94994-39-5 98%
1g
802.0CNY 2021-07-13
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-FZ296-250mg
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid
94994-39-5 98%
250mg
416CNY 2021-05-08
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-FZ296-100mg
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid
94994-39-5 98%
100mg
265CNY 2021-05-08
Chemenu
CM255963-1g
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic acid
94994-39-5 98%
1g
$147 2021-06-09
Chemenu
CM255963-5g
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic acid
94994-39-5 98%
5g
$421 2021-06-09
Chemenu
CM255963-10g
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic acid
94994-39-5 98%
10g
$673 2021-06-09
TRC
B810123-50mg
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic Acid
94994-39-5
50mg
45.00 2021-08-15
TRC
B810123-100mg
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic Acid
94994-39-5
100mg
$ 64.00 2023-04-18
TRC
B810123-500mg
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic Acid
94994-39-5
500mg
$ 190.00 2023-04-18

4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Production Method

Production Method 1

Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Isopropanol ,  Acetonitrile ;  overnight, rt
Reference
Preparation of carbamate prodrugs for inhibition of inosine monophosphate dehydrogenase (IMPDH)
, World Intellectual Property Organization, , ,

Production Method 2

Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: 1,4-Dioxane ;  0 °C; 24 h, rt
Reference
Aminopropyl thiazole derivatives useful as fungicides, and their preparation procedures
, Germany, , ,

Production Method 3

Reaction Conditions
1.1 Reagents: Sodium hydroxide Solvents: Dichloromethane ,  Water ;  48 h, rt
1.2 Reagents: Hydrochloric acid Solvents: Water ;  pH 5, rt
Reference
Peptoads, a group of amphiphilic long-chain triamides
Menger, Fredric M.; Zhang, Hailing, Langmuir, 2005, 21(23), 10428-10438

Production Method 4

Reaction Conditions
1.1 Reagents: Sodium hydride Solvents: Tetrahydrofuran
Reference
Total Synthesis of Cyclosporin on Solid-Phase Support
Gerber, Andreas, 2009, , ,

Production Method 5

Reaction Conditions
1.1 Reagents: Sodium hydride Solvents: Dimethylformamide ;  0 °C; 6 h, 0 °C
1.2 Reagents: Lithium hydroxide Solvents: Tetrahydrofuran ,  Water ;  overnight, rt
1.3 Reagents: Hydrochloric acid Solvents: Water ;  rt
Reference
Design, synthesis, and cyclization of 4-aminobutyric acid derivatives: potential candidates as self-immolative spacers
DeWit, Matthew A.; Gillies, Elizabeth R., Organic & Biomolecular Chemistry, 2011, 9(6), 1846-1854

Production Method 6

Reaction Conditions
1.1 Reagents: Hydrochloric acid Solvents: Water ;  18 h, reflux
1.2 Reagents: Sodium hydroxide Solvents: 1,4-Dioxane ,  Water ;  10 min, rt; rt → 0 °C
1.3 30 min, 0 °C; 12 h, rt
Reference
Synthesis and evaluation of xanomeline analogs-Probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor
Kane, Brian E.; Grant, Marianne K. O.; El-Fakahany, Esam E.; Ferguson, David M., Bioorganic & Medicinal Chemistry, 2008, 16(3), 1376-1392

Production Method 7

Reaction Conditions
1.1 Reagents: Sodium hydroxide Solvents: Water ;  16 h, 100 °C
1.2 Reagents: Sodium bicarbonate Solvents: Tetrahydrofuran ,  Water ;  14 h, rt
Reference
Preparation of 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as β-lactamase inhibitors
, World Intellectual Property Organization, , ,

Production Method 8

Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Dichloromethane ;  72 h, rt
Reference
Preparation of substituted quinolinone derivatives for use as muscarinic receptor antagonists and β2 adrenergic receptor agonists
, World Intellectual Property Organization, , ,

Production Method 9

Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Methanol ;  10 min, rt; 1 h, rt
Reference
Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
, World Intellectual Property Organization, , ,

Production Method 10

Reaction Conditions
1.1 Reagents: Sodium hydroxide Solvents: 1,4-Dioxane ,  Water ;  5 min, 0 °C; overnight, rt
1.2 Reagents: Hydrochloric acid Solvents: Water ;  pH 2 - 3
1.3 Reagents: Sodium hydride Solvents: Tetrahydrofuran ;  2 h, 0 °C
1.4 Solvents: Water ;  0 °C
1.5 Reagents: Hydrochloric acid Solvents: Water ;  pH 2 - 3
Reference
Fragment-based domain shuffling approach for the synthesis of pyran-based macrocyclic compounds
Comer, Eamon; Liu, Haibo; Joliton, Adrien; Clabaut, Alexandre; Johnson, Christopher; et al, Proceedings of the National Academy of Sciences of the United States of America, 2011, 108(17), 6751-6756

Production Method 11

Reaction Conditions
1.1 Reagents: Sodium hydride Solvents: Tetrahydrofuran ;  rt → 0 °C; 16 h, rt
1.2 Reagents: Water ;  rt
1.3 Reagents: Hydrochloric acid Solvents: Water ;  pH 3, rt
Reference
Antibody drug conjugates comprising STING modulators
, World Intellectual Property Organization, , ,

Production Method 12

Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Methanol ;  10 min, rt; 22 h, rt
Reference
DC-SiGN antibody conjugates comprising STING receptor agonists and their use in cancer therapy
, World Intellectual Property Organization, , ,

Production Method 13

Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Methanol ;  10 min, rt; 22 h, rt
Reference
Antibody conjugates comprising sting agonist
, World Intellectual Property Organization, , ,

Production Method 14

Reaction Conditions
1.1 Reagents: Sodium bicarbonate Solvents: 1,4-Dioxane ,  Water ;  20 min, 0 °C; 22 h, rt
Reference
Preparation of chemokine receptor binding (benzimidazol-2-ylmethyl)(5,6,7,8-tetrahydroquinolin-8-yl)amines and related heterocyclic compounds with enhanced efficacy against AIDS and other disorders
, United States, , ,

Production Method 15

Reaction Conditions
1.1 Reagents: Sodium hydroxide Solvents: Tetrahydrofuran ;  16 h, rt → 50 °C
1.2 Reagents: Hydrochloric acid Solvents: Water ;  pH 3 - 4
Reference
Lipid compound for cell transfection, and liposome and pharmaceutical composition comprising the same for treating genetic abnormality-induced disease
, China, , ,

Production Method 16

Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Methanol ;  rt; 2 h, rt
Reference
(R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-m ethylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt for the treatment of diseases such as cancer
, World Intellectual Property Organization, , ,

Production Method 17

Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Methanol ;  rt; 2 d, rt
Reference
Synthesis of Pyridazines or 1,2,4-Triazines containing spirocyclic amines treating cancers and diabetes
, World Intellectual Property Organization, , ,

Production Method 18

Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Dichloromethane ;  rt; 2 h, rt
Reference
Preparation of substituted spiro derivatives, especially, (R)-N-ethyl-5-fluoro-N-isopropyl-2-[[5-[2-[6-[(2-methoxyethyl)(methyl)amino]-2-methylhexan-3-yl]-2,6-diazaspiro[3.4]octan-6-yl]-1,2,4-triazin-6-yl]oxy]benzami de and its dibesylate as inhibitors of menin-MLL interaction and their use in combination with a BCl-2 inhibitor and optionally one other antitumor agents
, World Intellectual Property Organization, , ,

Production Method 19

Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Methanol ;  rt; 2 h, rt
Reference
Combination therapies
, World Intellectual Property Organization, , ,

4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Raw materials

4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Preparation Products

Recommended suppliers
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Shanghai Pearlk Chemicals Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
PRIBOLAB PTE.LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
PRIBOLAB PTE.LTD
Jinan Hanyu Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinan Hanyu Chemical Co.,Ltd.
Tiancheng Chemical (Jiangsu) Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk